CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-160 Cr | ₹-155 Cr | ₹-158 Cr | ₹-112 Cr | ₹-195 Cr |
What is the latest Cash Flow from Investing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-160 Cr |
| Mar2024 | ₹-155 Cr |
| Mar2023 | ₹-158 Cr |
| Mar2022 | ₹-112 Cr |
| Mar2021 | ₹-195 Cr |
How is Cash Flow from Investing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-160 Cr | Negative | |
| Mar2024 | ₹-155 Cr | Negative | |
| Mar2023 | ₹-158 Cr | Negative | |
| Mar2022 | ₹-112 Cr | Negative | |
| Mar2021 | ₹-195 Cr | - | |
Compare Cash Flow from Investing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,534.7 Cr | -1.8% | 0.8% | -20.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.8% |
0.8% |
-20.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses